SB
Strella Biotechnology, Inc.
SEC filingBiotechnology · Seattle, WA
Amount raised$1.8Msold at filing
Total offering$3.3M$1.5M still open
Investors in the raise35count reported to the SEC
FiledAug 14, 2026first sale Jun 29, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Katherine SizovExecutive Officer, Director, Promoter
Executive officers, directors and promoters as listed on the Form D.